Mats Wahlstrom, Director at Coherus BioSciences, Inc. (CHRS), sold 400,000 shares at $17.15 ($6.9M) on 2020-06-17, disclosed to the SEC on 2020-06-19.
Open-market sale of $6.9M CHRS by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $17.15 | 200,000 | $3.4M | 50.0% |
| 2 | $17.15 | 200,000 | $3.4M | 50.0% |
| Total | $17.15 avg | 400,000 | $6.9M | 100% |
| Filing → |
| TLSI | BUY | 2024-11-25 | $23K | — | Filing → |
| TLSI | BUY | 2024-11-22 | $47K | — | Filing → |
| CHRS | SELL | 2020-03-05 | $4.8M | — | Filing → |